Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

In conclusion, ICIs provide considerable benefit in Chinese cancer patients under optimal estimation.
Source: Frontiers of Medicine - Category: General Medicine Source Type: research